David M. O’SUllivan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
David M. O’SUllivan has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Elena Tunitsky-Bitton
Department of Urogynecology Hartford Hospital Hartford Connecticut USA
1 shared publication - Nicole J. Wood
Department of Urogynecology, Hartford Hospital, Hartford, CT
1 shared publication
Latest Publications
- 10 July 2026
- Published by Wolters Kluwer Health in Urogynecology
Chatbot Use by Patients Seeking Urogynecologic Consultation: A Randomized Trial
Importance: Urogynecology patients increasingly investigate their problems using technology-based resources, yet the effect of artificial intelligence (AI) chatbots on patient decision making remains unclear. Objective: The objective of this study was to investigate the effect of the use of an AI chatbot platform on patient decisional conflict during an initial urogynecology visit. Study Design: In this institutional review board-approved, single-center randomized trial, patients presenting with prolapse, incontinence, or lower urinary tract symptoms were assigned to 1 of 3 groups: (1) ChatGPT-4o (OpenAI) use before the visit, (2) after the visit, or (3) usual care without chatbot use. English- and Spanish-speaking participants used ChatGPT to ask questions about their primary concern. Demographics, prior information-seeking behavior, and visit details were collected. Surveys administered immediately and at 3 months assessed understanding of diagnosis and treatment, decisional conflict (Decisional Conflict Scale), visit satisfaction, and chatbot satisfaction. Chatbot transcripts were analyzed for readability. Results: Among 125 randomized patients (July 2024–December 2024), attrition at 3 months was 3.2%. Most participants were White (78.2%) with at least a high school education (92.8%), and 98.8% had no prior medical chatbot use. Demographics and diagnoses were similar across groups. Decisional conflict was low and did not differ immediately ( P = 0.691) or at 3 months ( P = 0.875). Understanding of diagnosis, visit satisfaction, and chatbot satisfaction were similar between groups. By 3 months, home chatbot use was more common in the intervention arms ( P = 0.011). Chatbot responses averaged an 11th–12th grade reading level. Conclusions: Patient use of a chatbot peri-visit did not affect decisional conflict. While increasingly accepted, chatbots may not yet optimally support urogynecologic patient-centered decision making.
- 10 July 2026
- Published by Wolters Kluwer Health in Urogynecology
Chatbot Use by Patients Seeking Urogynecologic Consultation: A Randomized Trial
Importance: Urogynecology patients increasingly investigate their problems using technology-based resources, yet the effect of artificial intelligence (AI) chatbots on patient decision making remains unclear. Objective: The objective of this study was to investigate the effect of the use of an AI chatbot platform on patient decisional conflict during an initial urogynecology visit. Study Design: In this institutional review board-approved, single-center randomized trial, patients presenting with prolapse, incontinence, or lower urinary tract symptoms were assigned to 1 of 3 groups: (1) ChatGPT-4o (OpenAI) use before the visit, (2) after the visit, or (3) usual care without chatbot use. English- and Spanish-speaking participants used ChatGPT to ask questions about their primary concern. Demographics, prior information-seeking behavior, and visit details were collected. Surveys administered immediately and at 3 months assessed understanding of diagnosis and treatment, decisional conflict (Decisional Conflict Scale), visit satisfaction, and chatbot satisfaction. Chatbot transcripts were analyzed for readability. Results: Among 125 randomized patients (July 2024–December 2024), attrition at 3 months was 3.2%. Most participants were White (78.2%) with at least a high school education (92.8%), and 98.8% had no prior medical chatbot use. Demographics and diagnoses were similar across groups. Decisional conflict was low and did not differ immediately ( P = 0.691) or at 3 months ( P = 0.875). Understanding of diagnosis, visit satisfaction, and chatbot satisfaction were similar between groups. By 3 months, home chatbot use was more common in the intervention arms ( P = 0.011). Chatbot responses averaged an 11th–12th grade reading level. Conclusions: Patient use of a chatbot peri-visit did not affect decisional conflict. While increasingly accepted, chatbots may not yet optimally support urogynecologic patient-centered decision making.